(Q38508187)

English

Hospitalized congestive heart failure patients with preserved versus abnormal left ventricular systolic function: clinical characteristics and drug therapy

scientific article published on December 1995

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

Hospitalized congestive heart failure patients with preserved versus abnormal left ventricular systolic function: clinical characteristics and drug therapy (English)

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

0 references

congestive heart failure

1 reference

based on heuristic

inferred from title

Mary M McDermott

1

object named as

McDermott MM

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

author name string

Feinglass J

2

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

Sy J

3

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

Gheorghiade M

4

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

language of work or name

0 references

publication date

1 December 1995

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

American Journal of Medicine

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

99

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

6

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

629-635

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

Heart failure with normal systolic function. Update of prevalence, differential diagnosis, prognosis, and therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980250-2

7 January 2021

Intact systolic left ventricular function in clinical congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980250-2

7 January 2021

Congestive heart failure: echocardiographic insights

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980250-2

7 January 2021

Congestive heart failure with normal systolic function

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980250-2

7 January 2021

Diagnosis and treatment of heart failure based on left ventricular systolic or diastolic dysfunction

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980250-2

7 January 2021

Effect of vasodilator therapy on mortality in chronic congestive heart failure. Results of a Veterans Administration Cooperative Study

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980250-2

7 January 2021

Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980250-2

7 January 2021

Randomized study assessing the effect of digoxin withdrawal in patients with mild to moderate chronic congestive heart failure: results of the PROVED trial. PROVED Investigative Group

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980250-2

7 January 2021

Withdrawal of digoxin from patients with chronic heart failure treated with angiotensin-converting-enzyme inhibitors. RADIANCE Study

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980250-2

7 January 2021

Usefulness of verapamil for congestive heart failure associated with abnormal left ventricular diastolic filling and normal left ventricular systolic performance

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980250-2

7 January 2021

Left ventricular diastolic dysfunction as a cause of congestive heart failure. Mechanisms and management

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980250-2

7 January 2021

Verapamil-induced improvement in left ventricular diastolic filling and increased exercise tolerance in patients with hypertrophic cardiomyopathy: short- and long-term effects.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980250-2

7 January 2021

Hypertensive hypertrophic cardiomyopathy of the elderly

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980250-2

7 January 2021

Effects of ouabain and isoproterenol on left ventricular diastolic function during low-flow ischemia in isolated, blood-perfused rabbit hearts

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980250-2

7 January 2021

The epidemiology of heart failure: the Framingham Study

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980250-2

7 January 2021

Left Ventricular Mass and Risk of Stroke in an Elderly Cohort

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980250-2

7 January 2021

Echocardiographic characterization of the reversible cardiomyopathy of hypothyroidism

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980250-2

7 January 2021

Reversible abnormalities of myocardial relaxation in hypothyroidism

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980250-2

7 January 2021

Left ventricular systolic and diastolic function in hyperthyroidism

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980250-2

7 January 2021

Congestive heart failure symptoms in patients with preserved left ventricular systolic function: Analysis of the CASS registry

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980250-2

7 January 2021

Need for a large randomized trial to evaluate the effects of digitalis on morbidity and mortality in congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980250-2

7 January 2021

Effects of gender and race on prognosis after myocardial infarction: adverse prognosis for women, particularly black women

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980250-2

7 January 2021

Adverse reactions with angiotensin converting enzyme (ACE) inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980250-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0002-9343(99)80250-2

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38508187&oldid=1762742735"